A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches
Open Access
- 1 May 2023
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (5) , 785
Abstract
Background: Oral beta-blockers are effective for heart failure and hypertension. Here, we conducted a prospective study to investigate the efficacy of the beta-blocker bisoprolol in patients switching from the oral tablet to the transdermal patch. Methods: We studied 50 outpatients receiving oral bisoprolol for chronic heart failure and hypertension. After patients switched treatments, we measured heart rate (HR) over 24 h by Holter echocardiography as the primary endpoint. Secondary endpoints were (1) HR at 00:00, 06:00, 12:00, and 18:00, (2) the total number of premature atrial contractions (PACs) over 24 h and the incidence rate per time segment, and the total number of premature ventricular contractions (PVCs) over 24 h and the incidence rate per time segment, (3) blood pressure, (4) atrial natriuretic peptide and B-type natriuretic peptide, and (5) echocardiography. Results: Minimum, maximum, mean, and total HR over 24 h was not significantly different between the two groups. Mean and maximum HR at 06:00, total PACs, total PVCs, and PVCs at 00:00 to 05:59 and 06:00 to 11:59 were significantly lower in the patch group. Conclusion: Compared with oral bisoprolol, the bisoprolol transdermal patch lowers HR at 06:00 and inhibits the onset of PVCs during sleep and in the morning.Keywords
This publication has 9 references indexed in Scilit:
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- Heart failure drug treatment: the fantastic fourEuropean Heart Journal, 2021
- Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study)Journal of Cardiology, 2019
- Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillationJournal of Cardiology, 2019
- Head‐to‐head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tabletCardiovascular Therapeutics, 2018
- Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart FailureCirculation Journal, 2018
- Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart diseaseJournal of Cardiology, 2017
- Comparison of Efficacy and Safety Between Bisoprolol Transdermal Patch (TY‐0201) and Bisoprolol Fumarate Oral Formulation in Japanese Patients With Grade I or II Essential Hypertension: Randomized, Double‐Blind, Placebo‐Controlled StudyThe Journal of Clinical Hypertension, 2013
- Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-AdrenoceptorsJournal of Cardiovascular Pharmacology, 2000